Jacobs Michael J, van Eps Randolph G Statius, de Jong Dick S, Schurink Geert Willem H, Mochtar Bas
Department of Surgery, University Hospital Maastricht, The Netherlands.
J Vasc Surg. 2004 Dec;40(6):1067-73; discussion 1073. doi: 10.1016/j.jvs.2004.08.055.
Renal failure is a potential complication after thoracoabdominal aortic aneurysm (TAAA) repair and is a significant risk factor for postoperative mortality. We assessed the results of distal aortic perfusion and continuous volume-controlled and pressure-controlled blood perfusion of the kidneys during TAAA repair in patients with preoperative normal and impaired renal function.
Surgical repair of TAAA was performed in 279 consecutive patients (type I, n = 90; type II, 117; type III, 42; type IV, 30). In 195 patients preoperative renal function was normal; however, in 84 patients renal insufficiency was diagnosed (serum creatinine concentration [SCr], 1.4-2.0 mg/dL, n = 46; SCr, 2.0-2.5 mg/dL, n = 20; and SCr, >2.5 mg/dL, n = 18). Renal perfusion was established with catheters connected to the left-sided heart bypass. Volume flow was assessed with ultrasound, and pressure channels in the catheters enabled pressure- controlled perfusion of the kidneys.
Selective renal artery perfusion was achieved in all patients without technical problems or complications. In each catheter, mean arterial pressure was 69 mm Hg and volume flow was 275 mL/min. During aortic cross-clamping, urine output was uninterrupted, irrespective of clamp time. Most patients demonstrated limited or moderate increase in SCr concentration. In 17 patients (6%) SCr doubled, and peaked above 3 mg/dL, but returned to baseline levels within several days. Three patients (1%) required temporary dialysis but were discharged without further need for dialysis. In general, preoperative renal impairment did not worsen.
Distal aortic and selective renal blood perfusion is an effective measure to protect renal function during TAAA repair, but only if perfusion is provided with adequate volume and pressure. This technique also averts dialysis in most patients with preoperative renal failure.
肾衰竭是胸腹主动脉瘤(TAAA)修复术后的一种潜在并发症,也是术后死亡率的一个重要危险因素。我们评估了术前肾功能正常和受损的患者在TAAA修复过程中进行远端主动脉灌注以及肾脏持续容量控制和压力控制血液灌注的结果。
连续279例患者接受了TAAA手术修复(I型,n = 90;II型,117;III型,42;IV型,30)。195例患者术前肾功能正常;然而,84例患者被诊断为肾功能不全(血清肌酐浓度[SCr],1.4 - 2.0mg/dL,n = 46;SCr,2.0 - 2.5mg/dL,n = 20;SCr,>2.5mg/dL,n = 18)。通过连接到左侧心脏旁路的导管建立肾脏灌注。用超声评估血流量,导管中的压力通道实现对肾脏的压力控制灌注。
所有患者均成功实现选择性肾动脉灌注,无技术问题或并发症。每个导管的平均动脉压为69mmHg,血流量为275mL/min。在主动脉交叉钳夹期间,尿量不受影响,与钳夹时间无关。大多数患者的SCr浓度仅有有限或中度升高。17例患者(6%)的SCr翻倍,峰值超过3mg/dL,但在数天内恢复到基线水平。3例患者(1%)需要临时透析,但出院后无需进一步透析。总体而言,术前肾功能损害没有加重。
远端主动脉和选择性肾血液灌注是TAAA修复过程中保护肾功能的有效措施,但前提是灌注要有足够的容量和压力。该技术还能避免大多数术前肾衰竭患者进行透析。